Editor(s):
(1) Dr. David E. Martin, DFH Pharma Inc., Maryland.
Reviewers:
(1) Aparecida Tiemi Nagao Dias, Universidade Federal Do Ceara, Brasil.
(2) Rita Vora, Bhaikaka University, India.
(3) Agnieszka Jabłońska, University Of Gdansk, Poland.
Additional Reviewers:
Open Peer Review Policy: Click Here
Specific Comment:
Average Peer review marks at initial stage: 6.7/10
Average Peer review marks at publication stage: 9/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer review report_1 (Aparecida Tiemi Nagao Dias, Brasil) | File 1 | NA
Stage 2 | Peer review report_2 (Rita Vora, India) | File 1 | NA
Stage 2 | Peer review report_3 (Agnieszka Jabłońska, Poland) | File 1 | File 2
Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2
Stage 3 | Comment_Editor_1_v1 | File 1 | NA